Efficacy of Sodium Cromoglicate in combination with nasal glucocorticoids in the treatment of drug-induced rhinitis: a multicenter randomized controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050716

Enrollment

Unknown

Registered

2021-09-03

Start date

2021-09-04

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rhinitis medichereasentosa

Interventions

Mometasone Furoate Aqueous Nasal Spray group:Mometasone Furoate Aqueous Nasal Spray was was given once a day for 4 weeks

Sodium Cromoglicate group:Sodium Cromoglicate was given 3 times a day for 4 weeks

Shuntomin and Neshuna combined treatment group:Mometasone Furoate Aqueous Nasal Spray was given once a day and Sodium Cromoglicate 3 times a day for 4 weeks

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: It meets the diagnostic criteria of drug-induced rhinitis.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

Measure	Time frame
Nasal endoscopy;VAS pain score;Sinus Outcome Test (SNOT) Score;	—

Countries

China

Contacts

Public ContactSong Xicheng

Yantai Yuhuangding Hospital

drxchsong@163.com+86 18005250077

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026